Takeda to present oncology portfolio and pipeline data at the 2024 asco annual meeting

Osaka, japan & cambridge, mass.--(business wire)--takeda (tse: 4502/nyse:tak) today announced that it will present data from its oncology pipeline and product portfolio at the 60th annual meeting of the american society of clinical oncology (asco) being held may 31-june 4, 2024, in chicago, ill. takeda's presentations will span across a range of cancers, including colorectal, lung, lymphoma, multiple myeloma and leukemia and feature both clinical and real-world data generated to optimize treatm.
TAK Ratings Summary
TAK Quant Ranking